Cargando…

Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention

PURPOSE OF REVIEW: Internationally, cardiovascular disease (CVD) is the leading cause of death in women. With risk factors for CVD continuing to rise, early identification and management of chronic diseases such as hypertension, diabetes, and obstructive sleep apnea is necessary for prevention. Preg...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Aarti, Hailu, Tigist, Blumenthal, Roger S., Martin, Seth S., Harrington, Colleen M., Yeh, Doreen DeFaria, French, Katharine A., Sharma, Garima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076812/
https://www.ncbi.nlm.nih.gov/pubmed/35524915
http://dx.doi.org/10.1007/s11883-022-01026-6
_version_ 1784702007251042304
author Thakkar, Aarti
Hailu, Tigist
Blumenthal, Roger S.
Martin, Seth S.
Harrington, Colleen M.
Yeh, Doreen DeFaria
French, Katharine A.
Sharma, Garima
author_facet Thakkar, Aarti
Hailu, Tigist
Blumenthal, Roger S.
Martin, Seth S.
Harrington, Colleen M.
Yeh, Doreen DeFaria
French, Katharine A.
Sharma, Garima
author_sort Thakkar, Aarti
collection PubMed
description PURPOSE OF REVIEW: Internationally, cardiovascular disease (CVD) is the leading cause of death in women. With risk factors for CVD continuing to rise, early identification and management of chronic diseases such as hypertension, diabetes, and obstructive sleep apnea is necessary for prevention. Pregnancy is a natural stress test for women with risk factors who may be predisposed to CVD and offers a unique opportunity to not only recognize disease but also implement effective and long-lasting strategies for prevention. RECENT FINDINGS: Prevention begins before pregnancy, as preconception screening, counseling, and optimization of chronic diseases can improve maternal and fetal outcomes. Throughout pregnancy, women should maintain close follow-up, continued reevaluation of risk factors, with counseling when necessary. Continued healthcare engagement during the “fourth trimester,” 3 months following delivery, allows clinicians to continue monitoring the evolution of chronic diseases, encourage ongoing lifestyle counseling, and connect women with primary care and appropriate specialists if needed. Unfortunately, this postpartum period represents a major care gap, as a significant proportion of most women do not attend their scheduled visits. Social determinants of health including decreased access to care and economic instability lead to increased risk factors throughout pregnancy but particularly play a role in poor compliance with postpartum follow-up. The use of telemedicine clinics and remote monitoring may prove to be effective interventions, bridging the gap between physicians and patients and improving follow-up for at-risk women. SUMMARY: While many clinicians are beginning to understand the impact of CVD on women, screening and prevention strategies are not often implemented until much later in life. Pregnancy creates an opportunity to begin engaging women in cardiovascular protective strategies before the development of the disease.
format Online
Article
Text
id pubmed-9076812
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-90768122022-05-09 Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention Thakkar, Aarti Hailu, Tigist Blumenthal, Roger S. Martin, Seth S. Harrington, Colleen M. Yeh, Doreen DeFaria French, Katharine A. Sharma, Garima Curr Atheroscler Rep Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor) PURPOSE OF REVIEW: Internationally, cardiovascular disease (CVD) is the leading cause of death in women. With risk factors for CVD continuing to rise, early identification and management of chronic diseases such as hypertension, diabetes, and obstructive sleep apnea is necessary for prevention. Pregnancy is a natural stress test for women with risk factors who may be predisposed to CVD and offers a unique opportunity to not only recognize disease but also implement effective and long-lasting strategies for prevention. RECENT FINDINGS: Prevention begins before pregnancy, as preconception screening, counseling, and optimization of chronic diseases can improve maternal and fetal outcomes. Throughout pregnancy, women should maintain close follow-up, continued reevaluation of risk factors, with counseling when necessary. Continued healthcare engagement during the “fourth trimester,” 3 months following delivery, allows clinicians to continue monitoring the evolution of chronic diseases, encourage ongoing lifestyle counseling, and connect women with primary care and appropriate specialists if needed. Unfortunately, this postpartum period represents a major care gap, as a significant proportion of most women do not attend their scheduled visits. Social determinants of health including decreased access to care and economic instability lead to increased risk factors throughout pregnancy but particularly play a role in poor compliance with postpartum follow-up. The use of telemedicine clinics and remote monitoring may prove to be effective interventions, bridging the gap between physicians and patients and improving follow-up for at-risk women. SUMMARY: While many clinicians are beginning to understand the impact of CVD on women, screening and prevention strategies are not often implemented until much later in life. Pregnancy creates an opportunity to begin engaging women in cardiovascular protective strategies before the development of the disease. Springer US 2022-05-07 2022 /pmc/articles/PMC9076812/ /pubmed/35524915 http://dx.doi.org/10.1007/s11883-022-01026-6 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)
Thakkar, Aarti
Hailu, Tigist
Blumenthal, Roger S.
Martin, Seth S.
Harrington, Colleen M.
Yeh, Doreen DeFaria
French, Katharine A.
Sharma, Garima
Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
title Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
title_full Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
title_fullStr Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
title_full_unstemmed Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
title_short Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
title_sort cardio-obstetrics: the next frontier in cardiovascular disease prevention
topic Evidence-Based Medicine, Clinical Trials and Their Interpretations (K. Nasir, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076812/
https://www.ncbi.nlm.nih.gov/pubmed/35524915
http://dx.doi.org/10.1007/s11883-022-01026-6
work_keys_str_mv AT thakkaraarti cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT hailutigist cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT blumenthalrogers cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT martinseths cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT harringtoncolleenm cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT yehdoreendefaria cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT frenchkatharinea cardioobstetricsthenextfrontierincardiovasculardiseaseprevention
AT sharmagarima cardioobstetricsthenextfrontierincardiovasculardiseaseprevention